FDA Approved: DEXRAZOXANE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a generic dexrazoxane (ANDA216748) from Novadoz Pharmaceuticals LLC under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthracycline-induced Cardiomyopathy
• Breast Cancer

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

ORIG AP for DEXRAZOXANE (DEXRAZOXANE)